Liver transplantation plus chemotherapy significantly improves overall survival in carefully selected patients with unresectable colorectal liver metastases compared with chemotherapy alone, according to the results of the TRANSMET trial. The combined approach led to a 5-year overall survival rate of 73% compared with 9% among those who received only chemotherapy…
